| 001 | 293813 | ||
| 005 | 20241217140438.0 | ||
| 024 | 7 | _ | |a 10.1080/14796694.2024.2402639 |2 doi |
| 024 | 7 | _ | |a pmid:39345094 |2 pmid |
| 024 | 7 | _ | |a 1479-6694 |2 ISSN |
| 024 | 7 | _ | |a 1744-8301 |2 ISSN |
| 037 | _ | _ | |a DKFZ-2024-01971 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Leypoldt, Lisa B |b 0 |
| 245 | _ | _ | |a Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma. |
| 260 | _ | _ | |a London |c 2024 |b Future Medicine Ltd |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1734440642_5827 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2024 Dec;20(39):3193-3207 |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a clinical trial |2 Other |
| 650 | _ | 7 | |a high-risk |2 Other |
| 650 | _ | 7 | |a isatuximab |2 Other |
| 650 | _ | 7 | |a multiple myeloma (MM) |2 Other |
| 650 | _ | 7 | |a plain language summary |2 Other |
| 700 | 1 | _ | |a Tichy, Diana |0 P:(DE-He78)2ef631585610340ff425c9c31fcabd03 |b 1 |u dkfz |
| 700 | 1 | _ | |a Besemer, Britta |b 2 |
| 700 | 1 | _ | |a Hanel, Mathias |b 3 |
| 700 | 1 | _ | |a Raab, Marc S |b 4 |
| 700 | 1 | _ | |a Mann, Christoph |b 5 |
| 700 | 1 | _ | |a Munder, Markus |b 6 |
| 700 | 1 | _ | |a Reinhardt, Hans Christian |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Nogai, Axel |b 8 |
| 700 | 1 | _ | |a Gorner, Martin |b 9 |
| 700 | 1 | _ | |a Ko, Yon-Dschun |b 10 |
| 700 | 1 | _ | |a Wit, Maike de |b 11 |
| 700 | 1 | _ | |a Salwender, Hans |b 12 |
| 700 | 1 | _ | |a Scheid, Christof |b 13 |
| 700 | 1 | _ | |a Graeven, Ullrich |b 14 |
| 700 | 1 | _ | |a Peceny, Rudolf |b 15 |
| 700 | 1 | _ | |a Staib, Peter |b 16 |
| 700 | 1 | _ | |a Dieing, Annette |b 17 |
| 700 | 1 | _ | |a Einsele, Hermann |b 18 |
| 700 | 1 | _ | |a Jauch, Anna |b 19 |
| 700 | 1 | _ | |a Hundemer, Michael |b 20 |
| 700 | 1 | _ | |a Zago, Manola |b 21 |
| 700 | 1 | _ | |a Pozek, Ema |0 P:(DE-He78)3cd8a9939d0a75acabca280ecc5ff77a |b 22 |u dkfz |
| 700 | 1 | _ | |a Benner, Axel |0 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |b 23 |u dkfz |
| 700 | 1 | _ | |a Bokemeyer, Carsten |b 24 |
| 700 | 1 | _ | |a Goldschmidt, Hartmut |b 25 |
| 700 | 1 | _ | |a Weisel, Katja C |b 26 |
| 773 | _ | _ | |a 10.1080/14796694.2024.2402639 |g p. 1 - 15 |0 PERI:(DE-600)2184533-5 |n 39 |p 3193-3207 |t Future oncology |v 20 |y 2024 |x 1479-6694 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:293813 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)2ef631585610340ff425c9c31fcabd03 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)3cd8a9939d0a75acabca280ecc5ff77a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-25 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-25 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b FUTURE ONCOL : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-25 |
| 920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l C060 Biostatistik |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)ED01-20160331 |k ED01 |l DKTK Koordinierungsstelle Essen/Düsseldorf |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C060-20160331 |
| 980 | _ | _ | |a I:(DE-He78)ED01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::